Autor: |
ILIAS, I. JAHAJ, E. KOKKORIS, S. ZERVAKIS, D. TEMPERIKIDIS, P. MAGIRA, E. PRATIKAKI, M. VASSILIOU, A.G. ROUTSI, C. KOTANIDOU, A. DIMOPOULOU, I. |
Jazyk: |
angličtina |
Rok vydání: |
2020 |
Popis: |
Background/Aim: Reports indicate that coronaviridae may inhibit insulin secretion. In this report we aimed to describe the course of glycemia in critically ill patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Patients and Methods: We studied 36 SARS-CoV-2 patients (with no history of diabetes) in one intensive care unit (ICU). All the patients were admitted for hypoxemic respiratory failure; all but four required mechanical ventilation. The mean (±SD) age of the patients was 64.7 (9.7) years; 27 were men; the mean (±SD) duration of ICU stay was 12.9 (8.3 days). Results: Twenty of 36 patients presented with hyperglycemia; brief intravenous infusions of short-acting insulin were administered in six patients. As of May 29 2020, 11 patients had died (seven with hyperglycemia). In 17 patients the Hyperglycemia Index [HGI; defined as the area under the curve of (hyper)glycemia level time (h) divided by the total time in the ICU] was |
Databáze: |
OpenAIRE |
Externí odkaz: |
|